Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 188.88B P/E 33.02 EPS this Y 4.30% Ern Qtrly Grth -7.10%
Income 5.61B Forward P/E 23.51 EPS next Y 11.00% 50D Avg Chg 2.00%
Sales 40.33B PEG 2.78 EPS past 5Y 9.85% 200D Avg Chg 3.00%
Dividend 2.00% Price/Book 5.10 EPS next 5Y 8.10% 52W High Chg -6.00%
Recommedations 2.00 Quick Ratio 0.95 Shares Outstanding 1.74B 52W Low Chg 16.00%
Insider Own 0.53% ROA 6.09% Shares Float 1.73B Beta 0.75
Inst Own 77.00% ROE 14.76% Shares Shorted/Prior 14.77M/12.94M Price 108.62
Gross Margin 55.27% Profit Margin 13.96% Avg. Volume 4,711,008 Target Price 125.80
Oper. Margin 15.41% Earnings Date Jul 18 Volume 4,699,325 Change -1.73%
About Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Abbott Laboratories News
05/24/24 Abbott (ABT) Stock Sinks As Market Gains: Here's Why
05/21/24 Wall Street Analysts See Abbott (ABT) as a Buy: Should You Invest?
05/21/24 Here's Why You Should Hold on to Abbott (ABT) Stock for Now
05/21/24 The Zacks Analyst Blog Highlights Stocks recently featured in the blog include: UnitedHealth, Danaher, Abbott and Ark Restaurants
05/20/24 Top Stock Reports for UnitedHealth, Danaher & Abbott
05/17/24 Abbott (ABT) Down 0.4% Since Last Earnings Report: Can It Rebound?
05/16/24 These Dividend Stocks Are an Investor's Best Friend
05/15/24 Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It
05/15/24 Abbott recalls Heartmate pump after 70 injuries, 2 deaths reported
05/09/24 Drugmaker Abbott India posts Q4 profit rise on higher sales
05/08/24 Insider Sale: Executive Vice President Lisa Earnhardt Sells 22,852 Shares of Abbott ...
05/08/24 Got $1,000? 3 Dividend Stocks to Buy and Hold Forever
05/08/24 The Zacks Analyst Blog Highlights Tesla, Johnson & Johnson, Netflix, Abbott and ConocoPhillips
05/07/24 13 Best Stocks That Will Always Grow
05/06/24 11 Best Recession Dividend Stocks To Buy
05/01/24 Stock Market Crash Alert: 3 Must-Buy Healthcare Stocks When Prices Plunge
05/01/24 Is Trending Stock Abbott Laboratories (ABT) a Buy Now?
04/30/24 PBH vs. ABT: Which Stock Is the Better Value Option?
04/30/24 7 Defensive Stocks Built to Withstand the Market’s Worst Storms
04/29/24 Abbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the Knee
ABT Chatroom

User Image Annihilous Posted - 31 minutes ago

$ABT why down so much today?

User Image designhawg Posted - 2 hours ago

$ABT South of 100 and I'll start accumulating weekly again. Bullish, but patient.

User Image terrin07 Posted - 3 hours ago

$ABT I bought started position earnings on July 18th coming the company is solid I think will be good but if not m ready to add for the turnaround 👍🏼

User Image nocap3s Posted - 1 day ago

$ABT $CELH pedialyte and celsius be like

User Image Thestocktraderhubzee Posted - 5 days ago

WATCHLIST MAY 23 2024. $IART Citigroup Maintains Neutral on Integra Lifesciences, Raises Price Target to $28 $BAX Citigroup Maintains Neutral on Baxter Intl, Lowers Price Target to $38 $ABT Citigroup Maintains Buy on Abbott Laboratories, Lowers Price Target to $119 $VLY Wedbush Reiterates Neutral on Valley Ntl, Maintains $8 Price Target $PPBI Wedbush Reiterates Neutral on Pacific Premier Bancorp, Maintains $25 Price Target

User Image designhawg Posted - 6 days ago

$ABT Life? Probably just jinxed it, but I'm gonna have to dig in to see if this is a turn or a head fake.

User Image kcphaeton Posted - 1 week ago

$ABT such a dog! Can’t we get a little daylight for Abbott.

User Image minter66 Posted - 1 week ago

$ABT trash

User Image Salahadin666 Posted - 1 week ago

$ABT this thing acts unwell

User Image Kups Posted - 1 week ago

$ABT boring

User Image HeyDuggee Posted - 1 week ago

$MDAI $ABT $JNJ Gamechanging Technology DYOR

User Image Professor Posted - 1 week ago

$ABT Weekly chart: Very weak name. Should get down to $97 next where I expect a bounce.

User Image SWilder Posted - 1 week ago

$NSPR shockingly cheap, has to be a buyout target for $ABT or someone right? Are there that many competitors in the stent space? Maybe there are

User Image kcphaeton Posted - 1 week ago

$ABT what a dog stock. Was hoping to get out even but I’m not sure we’ll ever see that dollar amount again. Have owned since November 21 down 30% does not make you feel good.

User Image ada3 Posted - 1 week ago

$KNW https://seekingalpha.com/article/4693733-know-labs-inc-knw-q2-2024-earnings-call-transcript Peter Conley Ron, if I could just amplify on what you're saying, part of what drives our excitement and enthusiasm literally every day is not a week goes by when we don't learn something new. And I'll give an example of that. Two weeks ago, the first week of May, in the Journal of Diabetes, Science and Technology, the peer review publication, a publication was included in the journal comparing the performance of the Dexcom G7 in the Abbott Freestyle Library. And we learned, contrary to Dexcom's stated MARD of 8.2%, that in the study, the overall rate was 15.1%. Now, we look at what we're doing, our most recently disclosed MARD is in the 11% range. And then we come to realize that there's a very high failure rate of the Dexcom G7, depending on the source, in that same peer review publication, indicated the failure rate was 35%, call it 1 and 3. We have seen from other postings and other sources, failure rate of 23%, call it 1 and 4. $DXCM $ABT

User Image ISEEU777 Posted - 1 week ago

$ABT

User Image Bullishmane Posted - 2 weeks ago

$ABT what are we doing here? So gross

User Image minter66 Posted - 2 weeks ago

$ABT Out with a loss. Screw this stock.

User Image Arooba2 Posted - 2 weeks ago

$ABT why is option flow bearish? What is catalyst? $XLV $RSP $XBI

User Image insiderbuyingselling Posted - 2 weeks ago

$ABT new insider selling: 22852 shares. http://insiderbuyingselling.com/?t=ABT

User Image CryptoLoka80 Posted - 2 weeks ago

$ABT we even got @bitboy_crypto talking about us tonite that’s crazy we don’t need so much exposure do we? 🤔💁‍♀️🚀❤️ $BTC.X

User Image sfl305 Posted - 2 weeks ago

$ABT.X Bitboy mentioned ARB Block during his morning show. Starts at 8:09 timestamp. He will make another video tonight highlighting $ABT as one of his top picks for May. https://youtube.com/live/zaE9a6jLlcQ?si=xAUD7e5dZ4BiwcOk

User Image CryptoLoka80 Posted - 2 weeks ago

$ABT.X Special shout out to the $ABT sellers for the discount! This will be 100$ in no time $TRB.X $ALEPH.X $BTC.X 💁‍♀️🚀💎 May29

User Image CryptoLoka80 Posted - 2 weeks ago

$ABT we hit triple bottom we going up after 8pm $BTC.X gonna start bull trend

User Image CryptoLoka80 Posted - 2 weeks ago

@Thesenutz8 $ABT Here’s the secret. It’s very simple. We are going to test the breakout at $3.05 and that’s where I think the low is. Like I said to a student in my discord last night. The more we try and stop it, the longer it’s going to take to pump. The bots will force it to test the breakout as that is the only area of liquidity to bounce off of. Remember our long term vision of $25 ABT 🚀🚀🚀 what’s the high again just bought that 3.10 yummy ass dip $BTC.X $ETH.X $FET.X

User Image CamSnipes8 Posted - 3 weeks ago

$ABT - - - buy at next 90 - - - sell at next 115 - - - repeat.

User Image minter66 Posted - 3 weeks ago

$ABT Roses are red, this stock is dead, today market is green, but this stock is more unstable than a bi-polar teen.

User Image DonCorleone77 Posted - 3 weeks ago

$ABT $BDX $ENOV $SYK $TWST Evercore ISI removes several healthcare names from 'Tactical Outperform' list Evercore ISI is removing Abbott (ABT), Becton Dickinson (BDX), Enovis (ENOV), Stryker (SYK), Illumina (ILMN) and Twist Bioscience (TWST) from the firm's "Tactical Outperform" list given that the earnings catalysts have passed. The firm still has Mesa Labs (MLAB), which will be reporting in the next three weeks, on the "Tactical Outperform" list, the analyst noted.

User Image StagflationRecession Posted - 3 weeks ago

$ABT support @$90 ??

User Image sfl305 Posted - 3 weeks ago

$ABT https://x.com/mave99a/status/1786836872674922535?s=12&t=VL1PH7kUaDuTSfkJqxJLpQ

Analyst Ratings
Citigroup Buy May 22, 24
Barclays Overweight Apr 22, 24
RBC Capital Outperform Apr 18, 24
Evercore ISI Group Outperform Apr 4, 24
Citigroup Buy Apr 3, 24
RBC Capital Outperform Feb 14, 24
Barclays Overweight Jan 26, 24
Citigroup Buy Jan 25, 24
RBC Capital Outperform Jan 25, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Wainer Andrea F EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Jan 29 Sell 112.5 42,500 4,781,250 65,027 01/31/24
Wainer Andrea F EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Jan 29 Option 52.17 42,500 2,217,225 82,527 01/31/24
Wainer Andrea F EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Dec 14 Sell 108 15,000 1,620,000 65,027 12/18/23
Wainer Andrea F EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Dec 14 Option 44.4 15,000 666,000 80,027 12/18/23
Wainer Andrea F EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Aug 08 Sell 105.95 10,400 1,101,880 65,027 08/10/23
Wainer Andrea F EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Aug 08 Option 38.4 5,000 192,000 75,427 08/10/23
STARKS DANIEL J Director Director Jul 27 Sell 113.72 50,000 5,686,000 6,775,316 07/28/23
Wainer Andrea F EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT May 02 Sell 110.56 8,226 909,467 70,427 05/03/23
Wainer Andrea F EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT May 02 Option 47 8,226 386,622 78,653 05/03/23
STARKS DANIEL J Director Director Apr 28 Sell 111.36 50,000 5,568,000 6,825,316 05/02/23
WOODGRIFT RANDEL WILLIAM SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT Feb 28 Sell 100.7 1,032 103,922 52,203 03/02/23
Morrone Louis H. SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT Feb 28 Sell 100.7 1,092 109,964 53,656 03/02/23
Moreland Mary K EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Feb 28 Sell 100.77 717 72,252 87,224 03/02/23
MANNING JOSEPH J EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Feb 28 Sell 100.7 1,339 134,837 62,323 03/02/23
Ginascol John F EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Feb 28 Sell 100.7 943 94,960 118,380 03/02/23
Funck, Jr. Robert E. EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Feb 28 Sell 100.7 1,264 127,285 218,237 03/02/23
Earnhardt Lisa D EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Feb 28 Sell 100.7 943 94,960 75,437 03/02/23
DALE MICHAEL D SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT Feb 28 Sell 100.7 1,209 121,746 45,133 03/02/23
ALLEN HUBERT L EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Feb 28 Sell 100.7 1,069 107,648 175,959 03/02/23
Ahlberg Gregory A SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT Feb 28 Sell 100.7 1,317 132,622 38,420 03/02/23
Karam Sammy SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT Dec 29 Sell 108.75 4,200 456,750 26,462 01/03/23
Ginascol John F EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Dec 13 Sell 112.32 11,000 1,235,520 111,912 12/15/22
STARKS DANIEL J Director Director Oct 27 Sell 97.72 50,000 4,886,000 6,873,500 10/31/22
MANNING JOSEPH J EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Sep 08 Option 44.4 23,008 1,021,555 76,253 09/09/22
MANNING JOSEPH J EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Sep 08 Sell 107 23,008 2,461,856 53,245 09/09/22
Ford Robert B CHAIRMAN AND CEO CHAIRMAN AND CEO Aug 25 Option 40.13 102,425 4,110,315 244,496 08/26/22
Ford Robert B CHAIRMAN AND CEO CHAIRMAN AND CEO Aug 25 Sell 105.1 102,425 10,764,868 142,071 08/26/22
MANNING JOSEPH J EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Aug 25 Option 44.4 23,008 1,021,555 80,143 08/26/22
MANNING JOSEPH J EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Aug 25 Sell 105.12 26,898 2,827,518 53,245 08/26/22
STARKS DANIEL J Director Director Jul 26 Sell 109.19 50,000 5,459,500 6,923,500 07/28/22
Mateus Fernando SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT Jul 26 Sell 109.0529 2,457 267,943 14,503 07/27/22
Tyler Julie L. SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT Jul 25 Sell 109.09 253 27,600 33,868 07/27/22
WOODGRIFT RANDEL WILLIAM SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT May 04 Option 44.4 24,000 1,065,600 71,854 05/05/22
WOODGRIFT RANDEL WILLIAM SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT May 04 Sell 113 24,000 2,712,000 47,854 05/05/22
STARKS DANIEL J Director Director May 03 Sell 113.55 50,000 5,677,500 6,973,500 05/05/22
DALE MICHAEL D SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT Mar 08 Sell 117.0003 4,000 468,001 41,780 03/10/22
WOODGRIFT RANDEL WILLIAM SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT Feb 28 Sell 118.1 964 113,848 49,223 03/02/22
Watkin Jared SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT Feb 28 Sell 118.1 1,038 122,588 66,545 03/02/22
Wainer Andrea F EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Feb 28 Sell 118.13 456 53,867 62,172 03/02/22
Salvadori Daniel Gesua Sive EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Feb 28 Sell 118.17 1,550 183,164 112,248 03/02/22
Morrone Louis H. SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT Feb 28 Sell 118.16 656 77,513 47,278 03/02/22
MANNING JOSEPH J EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Feb 28 Sell 118.16 779 92,047 60,873 03/02/22
Ginascol John F EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Feb 28 Sell 118.16 365 43,128 124,680 03/02/22
Earnhardt Lisa D EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Feb 28 Sell 118.15 943 111,415 90,630 03/02/22
DALE MICHAEL D SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT Feb 28 Sell 118.15 1,053 124,412 45,780 03/02/22
Calamari Christopher J. SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT Feb 28 Sell 118.15 706 83,414 25,658 03/02/22
ALLEN HUBERT L EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Feb 28 Sell 118.17 1,450 171,346 167,095 03/02/22
Ahlberg Gregory A SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT Feb 28 Sell 118.15 1,099 129,847 33,274 03/02/22
McKinstry Nancy Director Director Feb 24 Option 29.84 6,280 187,395 33,419 02/25/22
McKinstry Nancy Director Director Feb 24 Sell 116.43 1,614 187,918 31,805 02/25/22